Viking Therapeutics (VKTX) Misses Q1 EPS by 8c

Viking Therapeutics (NASDAQ: VKTX) reported Q1 EPS of ($0.41), $0.08 worse than the analyst estimate of ($0.33).

For earnings history and earnings-related data on Viking Therapeutics (VKTX) click here.

You May Also Be Interested In

• BofA Securities Double Upgrades Renishaw Plc. (RSW:LN) (RNSHY) to Buy
• Samsara Inc (IOT) Tops Q2 EPS by 4c, Beats on Revenue; Offers Q3 Guidance
• lululemon athletica (LULU) Tops Q2 EPS by $1.10, Cuts Guidance